Cabaletta Bio
CABA
159 hedge funds and large institutions have $871M invested in Cabaletta Bio in 2024 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 46 increasing their positions, 47 reducing their positions, and 15 closing their positions.
207% more first-time investments, than exits
New positions opened: 46 | Existing positions closed: 15
24% more funds holding
Funds holding: 128 → 159 (+31)
2% less repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 47
7.45% less ownership
Funds ownership: 113.28% → 105.83% (-7.5%)
21% less capital invested
Capital invested by funds: $1.1B → $871M (-$231M)
43% less call options, than puts
Call options by funds: $8.87M | Put options by funds: $15.6M
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
+$38.6M |
| 2 |
State Street
Boston,
Massachusetts
|
+$24.6M |
| 3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$23.6M |
| 4 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$13.7M |
| 5 |
SC
Stempoint Capital
New York
|
+$11.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Holocene Advisors
New York
|
-$43.6M |
| 2 |
VA
VR Adviser
New York
|
-$21.5M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
-$20M |
| 4 |
CC
Commodore Capital
New York
|
-$17.2M |
| 5 |
DM
Deerfield Management
New York
|
-$16.1M |
CABA Hedge Fund Activity: Q1 2024 in Review
159 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Cabaletta Bio (CABA) for Q1 2024, worth a combined $871M — down 21% from $1.1B a quarter earlier.
Buyers outnumbered sellers: 46 funds opened new CABA positions and 15 closed out — a net gain of 31 holders — while 46 added to existing stakes and 47 trimmed.
The largest buyer was Jennison Associates, adding an estimated $38.6M. The largest seller was Holocene Advisors, exiting entirely with an estimated $43.6M sold.
- 159 institutional investors held Cabaletta Bio (CABA) as of Q1 2024, up from 128 in Q4 2023.
- Funds reported $871M of Cabaletta Bio stock for Q1 2024, down 21% quarter-over-quarter.
- 46 funds opened new Cabaletta Bio positions in Q1 2024 and 15 closed out, a net change of +31 holders.
- The largest Cabaletta Bio buyer in Q1 2024 was Jennison Associates, an estimated $38.6M added.
- The largest Cabaletta Bio seller in Q1 2024 was Holocene Advisors, an estimated $43.6M sold.
Based on aggregated 13F filings for Q1 2024.